Tarik Skubal wins arbitration for record $32 million salary

Tarik Skubal, the Detroit Tigers' ace pitcher, has won his salary arbitration case against the team, securing a record $32 million for the 2026 season. The ruling surpasses previous benchmarks for arbitration-eligible players and pitchers alike. This victory comes amid ongoing trade speculation, though the Tigers have expressed no intent to deal him.

Reigning two-time American League Cy Young Award winner Tarik Skubal prevailed in his arbitration hearing against the Detroit Tigers, as reported by ESPN and MLB.com. A three-person panel selected Skubal's proposed $32 million salary for 2026 over the team's $19 million filing, creating the largest gap—$13 million—in arbitration history.

This marks the highest salary ever awarded to an arbitration-eligible player, eclipsing Juan Soto's $31 million in 2024 with the Yankees. For pitchers, it shatters David Price's $19.75 million record from 2015, also with the Tigers. Skubal's raise of $21.85 million from his 2025 salary of $10.15 million exceeds Jacob deGrom's previous high of $9.6 million.

Represented by agent Scott Boras, Skubal, entering his final arbitration year with five-plus years of service, compared his value to top free-agent pitchers like Zack Wheeler ($42 million), Jacob deGrom ($38 million), and Gerrit Cole ($36 million). The hearing occurred on Wednesday, with the decision announced Thursday. The Tigers, a 'file and trial' team, hadn't lost an arbitration case since 2000.

Skubal's win elevates the salary benchmark for elite pitchers, benefiting the players' union. At 29, he posted a league-leading 2.21 ERA, 241 strikeouts, and 195 1/3 innings in 2025, helping the Tigers to an 87-75 record and an ALDS loss to the Mariners. The team recently signed Framber Valdez to a three-year, $115 million deal (average annual value $38 million), making Skubal their second-highest paid player in 2026.

Trade rumors have swirled due to Skubal's impending free agency and Boras' involvement, but reports indicate the Tigers plan to retain him, potentially bolstering their rotation with Valdez, Jack Flaherty, Casey Mize, Reese Olson, and Troy Melton.

Liittyvät artikkelit

Tarik Skubal pitching dominantly for Team USA in World Baseball Classic victory over Great Britain.
AI:n luoma kuva

Tarik Skubal considers second start for Team USA in World Baseball Classic

Raportoinut AI AI:n luoma kuva

Tarik Skubal, the Detroit Tigers' ace and back-to-back AL Cy Young winner, is rethinking his plan to make just one start in the 2026 World Baseball Classic after his debut for Team USA. The 29-year-old pitcher impressed in a 9-1 victory over Great Britain, allowing one run in three innings. He plans to decide in the next few days after discussions with his team, agent, and family.

Detroit Tigers left-hander Tarik Skubal will undergo surgery to remove loose bodies from his elbow after the team announced the procedure on Monday. The two-time Cy Young winner is expected to miss two to three months, raising questions about his performance and contract value heading into free agency after the 2026 season.

Raportoinut AI

Detroit Tigers ace Tarik Skubal, the two-time defending American League Cy Young winner, will undergo arthroscopic surgery to remove loose bodies from his elbow following a flare-up. Neither Skubal nor the team has provided a specific timetable for his return, though recovery typically takes two to three months. The injury led to him being scratched from his Monday start against the Red Sox.

Detroit Tigers ace Tarik Skubal has taken another step in his recovery from elbow surgery. The left-hander threw a full bullpen session with no symptoms less than two weeks after the procedure.

Raportoinut AI

Spencer Torkelson hit a walk-off home run to give the Detroit Tigers a 5-4 victory over the Milwaukee Brewers at Comerica Park on Thursday afternoon. The win secured the series for Detroit after Tarik Skubal surrendered a game-tying double in the seventh inning. Jahmai Jones also homered earlier to help rally the Tigers.

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää